دورية أكاديمية

European Perspective on Multiple Myeloma Treatment Strategies: Update Following Recent Congresses.

التفاصيل البيبلوغرافية
العنوان: European Perspective on Multiple Myeloma Treatment Strategies: Update Following Recent Congresses.
المؤلفون: LUDWIG, HEINZ, AVET-LOISEAU, HERV, BLAD, JOAN, BOCCADORO, MARIO, CAVENAGH, JAMIE, CAVO, MICHELE, DAVIES, FAITH, DE LA RUBIA, JAVIER, DELIMPASI, SOSANA, DIMOPOULOS, MELETIOS, DRACH, JOHANNES, EINSELE, HERMANN, FACON, THIERRY, GOLDSCHMIDT, HARTMUT, HESS, URS, MELLQVIST, ULF-HENRIK, MOREAU, PHILIPPE, SAN-MIGUEL, JESéS, SONDERGELD, PIA, SONNEVELD, PIETER
المصدر: Oncologist; May2012, Vol. 17 Issue 5, following p592-606, 16p, 2 Diagrams, 5 Charts
مصطلحات موضوعية: ANTINEOPLASTIC agents, COMBINATION drug therapy, FRAIL elderly, GENES, HEMATOPOIETIC stem cell transplantation, MULTIPLE myeloma, QUALITY of life, RISK assessment, THALIDOMIDE, DISEASE relapse, PROGNOSIS, THERAPEUTICS
مصطلحات جغرافية: EUROPE
مستخلص: The management of multiple myeloma has undergone profound changes over the recent past as a result of advances in our understanding of the disease biology as well as improvements in treatment and supportive care strategies. Notably, recent years have seen a surge in studies incorporating the novel agents thalidomide, bortezomib, and lenalidomide into treatment for different disease stages and across different patient groups. This article presents an update to a previous review of European treatment practices and is based on discussions during an expert meeting that was convened to review novel agent data published or presented at medical meetings until the end of 2011 and to assess their impact on treatment strategies. [ABSTRACT FROM AUTHOR]
Copyright of Oncologist is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
ResultId 1
Header edb
Complementary Index
76413992
834
6
Academic Journal
academicJournal
834.334411621094
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=76413992&custid=s6537998&authtype=sso
FullText Array ( [Availability] => 0 )
Array ( [0] => Array ( [Url] => https://resolver.ebscohost.com/openurl?custid=s6537998&groupid=main&authtype=ip,guest&sid=EBSCO:edb&genre=article&issn=10837159&ISBN=&volume=17&issue=5&date=20120501&spage=592&pages=592-607&title=Oncologist&atitle=European%20Perspective%20on%20Multiple%20Myeloma%20Treatment%20Strategies%3A%20Update%20Following%20Recent%20Congresses.&id=DOI:10.1634/theoncologist.2011-0391 [Name] => Full Text Finder (s6537998api) [Category] => fullText [Text] => Full Text Finder [Icon] => https://imageserver.ebscohost.com/branding/images/FTF.gif [MouseOverText] => Full Text Finder ) )
Items Array ( [Name] => Title [Label] => Title [Group] => Ti [Data] => European Perspective on Multiple Myeloma Treatment Strategies: Update Following Recent Congresses. )
Array ( [Name] => Author [Label] => Authors [Group] => Au [Data] => <searchLink fieldCode="AR" term="%22LUDWIG%2C+HEINZ%22">LUDWIG, HEINZ</searchLink><br /><searchLink fieldCode="AR" term="%22AVET-LOISEAU%2C+HERV%22">AVET-LOISEAU, HERV</searchLink><br /><searchLink fieldCode="AR" term="%22BLAD%2C+JOAN%22">BLAD, JOAN</searchLink><br /><searchLink fieldCode="AR" term="%22BOCCADORO%2C+MARIO%22">BOCCADORO, MARIO</searchLink><br /><searchLink fieldCode="AR" term="%22CAVENAGH%2C+JAMIE%22">CAVENAGH, JAMIE</searchLink><br /><searchLink fieldCode="AR" term="%22CAVO%2C+MICHELE%22">CAVO, MICHELE</searchLink><br /><searchLink fieldCode="AR" term="%22DAVIES%2C+FAITH%22">DAVIES, FAITH</searchLink><br /><searchLink fieldCode="AR" term="%22DE+LA+RUBIA%2C+JAVIER%22">DE LA RUBIA, JAVIER</searchLink><br /><searchLink fieldCode="AR" term="%22DELIMPASI%2C+SOSANA%22">DELIMPASI, SOSANA</searchLink><br /><searchLink fieldCode="AR" term="%22DIMOPOULOS%2C+MELETIOS%22">DIMOPOULOS, MELETIOS</searchLink><br /><searchLink fieldCode="AR" term="%22DRACH%2C+JOHANNES%22">DRACH, JOHANNES</searchLink><br /><searchLink fieldCode="AR" term="%22EINSELE%2C+HERMANN%22">EINSELE, HERMANN</searchLink><br /><searchLink fieldCode="AR" term="%22FACON%2C+THIERRY%22">FACON, THIERRY</searchLink><br /><searchLink fieldCode="AR" term="%22GOLDSCHMIDT%2C+HARTMUT%22">GOLDSCHMIDT, HARTMUT</searchLink><br /><searchLink fieldCode="AR" term="%22HESS%2C+URS%22">HESS, URS</searchLink><br /><searchLink fieldCode="AR" term="%22MELLQVIST%2C+ULF-HENRIK%22">MELLQVIST, ULF-HENRIK</searchLink><br /><searchLink fieldCode="AR" term="%22MOREAU%2C+PHILIPPE%22">MOREAU, PHILIPPE</searchLink><br /><searchLink fieldCode="AR" term="%22SAN-MIGUEL%2C+JESéS%22">SAN-MIGUEL, JESéS</searchLink><br /><searchLink fieldCode="AR" term="%22SONDERGELD%2C+PIA%22">SONDERGELD, PIA</searchLink><br /><searchLink fieldCode="AR" term="%22SONNEVELD%2C+PIETER%22">SONNEVELD, PIETER</searchLink> )
Array ( [Name] => TitleSource [Label] => Source [Group] => Src [Data] => Oncologist; May2012, Vol. 17 Issue 5, following p592-606, 16p, 2 Diagrams, 5 Charts )
Array ( [Name] => Subject [Label] => Subject Terms [Group] => Su [Data] => <searchLink fieldCode="DE" term="%22ANTINEOPLASTIC+agents%22">ANTINEOPLASTIC agents</searchLink><br /><searchLink fieldCode="DE" term="%22COMBINATION+drug+therapy%22">COMBINATION drug therapy</searchLink><br /><searchLink fieldCode="DE" term="%22FRAIL+elderly%22">FRAIL elderly</searchLink><br /><searchLink fieldCode="DE" term="%22GENES%22">GENES</searchLink><br /><searchLink fieldCode="DE" term="%22HEMATOPOIETIC+stem+cell+transplantation%22">HEMATOPOIETIC stem cell transplantation</searchLink><br /><searchLink fieldCode="DE" term="%22MULTIPLE+myeloma%22">MULTIPLE myeloma</searchLink><br /><searchLink fieldCode="DE" term="%22QUALITY+of+life%22">QUALITY of life</searchLink><br /><searchLink fieldCode="DE" term="%22RISK+assessment%22">RISK assessment</searchLink><br /><searchLink fieldCode="DE" term="%22THALIDOMIDE%22">THALIDOMIDE</searchLink><br /><searchLink fieldCode="DE" term="%22DISEASE+relapse%22">DISEASE relapse</searchLink><br /><searchLink fieldCode="DE" term="%22PROGNOSIS%22">PROGNOSIS</searchLink><br /><searchLink fieldCode="DE" term="%22THERAPEUTICS%22">THERAPEUTICS</searchLink> )
Array ( [Name] => SubjectGeographic [Label] => Geographic Terms [Group] => Su [Data] => <searchLink fieldCode="DE" term="%22EUROPE%22">EUROPE</searchLink> )
Array ( [Name] => Abstract [Label] => Abstract [Group] => Ab [Data] => The management of multiple myeloma has undergone profound changes over the recent past as a result of advances in our understanding of the disease biology as well as improvements in treatment and supportive care strategies. Notably, recent years have seen a surge in studies incorporating the novel agents thalidomide, bortezomib, and lenalidomide into treatment for different disease stages and across different patient groups. This article presents an update to a previous review of European treatment practices and is based on discussions during an expert meeting that was convened to review novel agent data published or presented at medical meetings until the end of 2011 and to assess their impact on treatment strategies. [ABSTRACT FROM AUTHOR] )
Array ( [Name] => Abstract [Label] => [Group] => Ab [Data] => <i>Copyright of Oncologist is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.) )
RecordInfo Array ( [BibEntity] => Array ( [Identifiers] => Array ( [0] => Array ( [Type] => doi [Value] => 10.1634/theoncologist.2011-0391 ) ) [Languages] => Array ( [0] => Array ( [Code] => eng [Text] => English ) ) [PhysicalDescription] => Array ( [Pagination] => Array ( [PageCount] => 16 [StartPage] => 592 ) ) [Subjects] => Array ( [0] => Array ( [SubjectFull] => EUROPE [Type] => general ) [1] => Array ( [SubjectFull] => ANTINEOPLASTIC agents [Type] => general ) [2] => Array ( [SubjectFull] => COMBINATION drug therapy [Type] => general ) [3] => Array ( [SubjectFull] => FRAIL elderly [Type] => general ) [4] => Array ( [SubjectFull] => GENES [Type] => general ) [5] => Array ( [SubjectFull] => HEMATOPOIETIC stem cell transplantation [Type] => general ) [6] => Array ( [SubjectFull] => MULTIPLE myeloma [Type] => general ) [7] => Array ( [SubjectFull] => QUALITY of life [Type] => general ) [8] => Array ( [SubjectFull] => RISK assessment [Type] => general ) [9] => Array ( [SubjectFull] => THALIDOMIDE [Type] => general ) [10] => Array ( [SubjectFull] => DISEASE relapse [Type] => general ) [11] => Array ( [SubjectFull] => PROGNOSIS [Type] => general ) [12] => Array ( [SubjectFull] => THERAPEUTICS [Type] => general ) ) [Titles] => Array ( [0] => Array ( [TitleFull] => European Perspective on Multiple Myeloma Treatment Strategies: Update Following Recent Congresses. [Type] => main ) ) ) [BibRelationships] => Array ( [HasContributorRelationships] => Array ( [0] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => LUDWIG, HEINZ ) ) ) [1] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => AVET-LOISEAU, HERV ) ) ) [2] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => BLAD, JOAN ) ) ) [3] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => BOCCADORO, MARIO ) ) ) [4] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => CAVENAGH, JAMIE ) ) ) [5] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => CAVO, MICHELE ) ) ) [6] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => DAVIES, FAITH ) ) ) [7] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => DE LA RUBIA, JAVIER ) ) ) [8] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => DELIMPASI, SOSANA ) ) ) [9] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => DIMOPOULOS, MELETIOS ) ) ) [10] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => DRACH, JOHANNES ) ) ) [11] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => EINSELE, HERMANN ) ) ) [12] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => FACON, THIERRY ) ) ) [13] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => GOLDSCHMIDT, HARTMUT ) ) ) [14] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => HESS, URS ) ) ) [15] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => MELLQVIST, ULF-HENRIK ) ) ) [16] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => MOREAU, PHILIPPE ) ) ) [17] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => SAN-MIGUEL, JESéS ) ) ) [18] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => SONDERGELD, PIA ) ) ) [19] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => SONNEVELD, PIETER ) ) ) ) [IsPartOfRelationships] => Array ( [0] => Array ( [BibEntity] => Array ( [Dates] => Array ( [0] => Array ( [D] => 01 [M] => 05 [Text] => May2012 [Type] => published [Y] => 2012 ) ) [Identifiers] => Array ( [0] => Array ( [Type] => issn-print [Value] => 10837159 ) ) [Numbering] => Array ( [0] => Array ( [Type] => volume [Value] => 17 ) [1] => Array ( [Type] => issue [Value] => 5 ) ) [Titles] => Array ( [0] => Array ( [TitleFull] => Oncologist [Type] => main ) ) ) ) ) ) )
IllustrationInfo